Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may Serve as a Biomarker for its Efficacy Against Human Breast Cancer and Melanoma Cells

Autor: Mehta, R. R., Hawthorne, M. E., Graves, J. M., Mehta, R. G.
Zdroj: European Journal of Cancer; 1998, Vol. 34 Issue: 6 p902-907, 6p
Databáze: Supplemental Index